A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours
Phase 1
Recruiting
- Conditions
- Cancer: Recurrent and/or Metastatic Solid Tumours
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- PharmaMatrix Holdings Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT04823897
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath